Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats

Chronobiol Int. 2002 Nov;19(6):1121-36. doi: 10.1081/cbi-120015957.

Abstract

This study investigates if the serotoninergic system plays a role in chronotoxic effects of the anticancer agent oxaliplatin (l-OHP). Four groups of female rats (120 in total) synchronized with light-dark (12 h:12 h) were treated with: (i) saline, (ii) para-chlorophenylalanine (pCPA, an inhibitor of serotonin biosynthesis: 300 mg/kg/d, i.p. for two consecutive days), (iii) l-OHP (23 mg/kg, i.v.) at three different dosing times, or (iv) both pCPA and l-OHP. The results show pCPA (ii) obliterates the circadian rhythm in plasma ACTH but not in corticosterone or leukocytes, and (iii) l-OHP exerts circadian time-dependent toxic effects (body weight loss, leukopenia, and intestinal lesions) with greatest toxicity coinciding with treatment at the end of the nocturnal activity span (P < 0.05). In rats whose serotonin biosynthesis was blocked (iv), the circadian rhythms in the toxic effects of l-OHP and in ACTH were obliterated, while the rhythms in corticosterone and leukocytes persisted.

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Animals
  • Antineoplastic Agents / toxicity*
  • Biological Clocks / physiology
  • Body Weight
  • Circadian Rhythm / physiology*
  • Corticosterone / blood
  • Digestive System Physiological Phenomena
  • Enzyme Inhibitors / metabolism
  • Female
  • Fenclonine / metabolism
  • Immune System / physiology
  • Leukocytes / metabolism
  • Organoplatinum Compounds / toxicity*
  • Oxaliplatin
  • Photoperiod
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / biosynthesis*
  • Serotonin Antagonists / metabolism

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Organoplatinum Compounds
  • Serotonin Antagonists
  • Oxaliplatin
  • Serotonin
  • Adrenocorticotropic Hormone
  • Fenclonine
  • Corticosterone